Pharmacological Alterations of Anxious Behaviour in Mice Depending on Both Strain and the Behavioural Situation

被引:26
作者
Clement, Yan
Le Guisquet, Anne-Marie
Venault, Patrice
Chapouthier, Georges
Belzung, Catherine
机构
[1] Université Reims Champagne-Ardenne, Reims
[2] Departement de Psychobiologie des Émotions, Université François Rabelaisde Tours, Faculté des Sciences et Techniques, Parc Grandmont, Tours
[3] Université Pierre et Marie Curie-Paris 6, CNRS, UMR 7225, Paris
[4] USR, CNRS, 3246 Groupe Hospitalier Pitié-Salpêtrière, Paris
关键词
ELEVATED PLUS-MAZE; FREE-EXPLORATORY PARADIGM; ANXIETY-RELATED BEHAVIORS; GABA(A) RECEPTORS; ANIMAL-MODELS; GENETIC-BASIS; FLUMAZENIL BLOCKS; SWISS-WEBSTER; BENZODIAZEPINE; ANTAGONIST;
D O I
10.1371/journal.pone.0007745
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A previous study comparing non-emotive mice from the strain C57BL/6/ByJ with ABP/Le mice showed ABP/Le to be more anxious in an open-field situation. In the present study, several compounds affecting anxiety were assayed on ABP/Le and C57BL/6/ByJ mice using three behavioural models of anxiety: the elevated plus-maze, the light-dark discrimination test and the free exploratory paradigm. The compounds used were the full benzodiazepine receptor agonist, chlordiazepoxide, and the antagonist, flumazenil, the GABA(A) antagonist, bicuculline, the full 5-HT1A agonist 8-OH-DPAT, and the mixed 5-HT1A/5-HT1B agonist, RU 24969. Results showed the effect of the compounds to be dependent on both the strain and the behavioural task. Several compounds found to be anxiolytic in ABP/Le mice had an anxiogenic effect on C57BL/6/ByJ mice. More behavioural changes were observed for ABP/Le in the elevated plus-maze, but the clearest findings for C57BL/6/ByJ mice were observed in the light-dark discrimination apparatus. These data demonstrate that anxious behaviour is a complex phenomenon which cannot be described by a single behavioural task nor by the action of a single compound.
引用
收藏
页码:A74 / A81
页数:8
相关论文
共 86 条
[1]  
Ågmo A, 1999, PSYCHOBIOLOGY, V27, P105
[2]  
AGMO A, 1991, N-S ARCH PHARMACOL, V344, P314
[3]   Interactions between dopamine and GABA in the control of ambulatory activity and neophobia in the mouse [J].
Ågmo, A ;
Belzung, C .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (01) :239-247
[4]   ANXIOGENIC EFFECTS OF METHYL-BETA-CARBOLINE-3-CARBOXYLATE IN A LIGHT DARK CHOICE SITUATION [J].
BELZUNG, C ;
MISSLIN, R ;
VOGEL, E ;
DODD, RH ;
CHAPOUTHIER, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (01) :29-33
[5]   Naloxone blocks anxiolytic-like effects of benzodiazepines in Swiss but not in Balb/c mice [J].
Belzung, C ;
Agmo, A .
PSYCHOPHARMACOLOGY, 1997, 132 (02) :195-201
[6]   Measuring normal and pathological anxiety-like behaviour in mice: a review [J].
Belzung, C ;
Griebel, G .
BEHAVIOURAL BRAIN RESEARCH, 2001, 125 (1-2) :141-149
[7]   Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice [J].
Belzung, C ;
Dubreuil, D .
BEHAVIOURAL PHARMACOLOGY, 1998, 9 (08) :691-698
[8]   Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety [J].
Belzung, C ;
Berton, F .
BEHAVIOURAL PHARMACOLOGY, 1997, 8 (6-7) :541-548
[9]   The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models [J].
Belzung, C .
BEHAVIOURAL PHARMACOLOGY, 2001, 12 (6-7) :451-460
[10]  
BELZUNG C, 1988, PSYCHOPHARMACOLOGY, V95, P516